|
76
|
258
|
3m5eA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[n-(6-chloro-5-formyl-2-methylthiopyrimidin-4-yl)amino]methyl}benzenesulfonamide |
|
78
|
257
|
3m2zA |
Fragment tethered to carbonic anhydrase ii h64c mutant |
|
78
|
255
|
3m1wA |
Carbonic anhyrdase ii mutant w5ch64c with closed disulfide bond in complex with sulfate |
|
75
|
257
|
3mhiA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(5-nitro-6-oxo-1,6-dihydro-4-pyrimidinyl)amino]methyl}benzenesulfonamide |
|
75
|
258
|
3m3xA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{2-[n-(6-methoxy-5-nitropyrimidin-4-yl)amino]ethyl}benzenesulfonamide |
|
76
|
257
|
3m1jA |
The crystal structure of a nami a-carbonic anhydrase ii adduct discloses the mode of action of this novel anticancer metallodrug |
|
79
|
257
|
3mhmA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[n-(6-benzylamino-5-nitropyrimidin-4-yl)amino]methyl}benzenesulfonamide |
|
76
|
258
|
3m40A |
Crystal structure of human carbonic anhydrase isozyme ii with 4-[n-(6-chloro-5-nitropyrimidin-4-yl)amino]benzenesulfonamide |
|
75
|
258
|
3m2yA |
Carbonic anhydrase ii in complex with novel sulfonamide inhibitor |
|
75
|
257
|
3m2xA |
Carbonic anhydrase ii in complex with novel sulfonamide inhibitor |
|
74
|
257
|
3m98A |
Crystal structure of human carbonic anhydrase isozyme ii with 5-(1h-benzimidazol-1-ylacetyl)-2-chlorobenzenesulfonamide |
|
77
|
258
|
3m2nA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{2-[n-(6-chloro-5-nitropyrimidin-4-yl)amino]ethyl}benzenesulfonamide |
|
76
|
255
|
3m04A |
Carbonic anhydrase ii in complex with novel sulfonamide inhibitor |
|
75
|
256
|
3lxeA |
Human carbonic anhydrase i in complex with topiramate |
|
73
|
257
|
3l14A |
Human carbonic anhydrase ii complexed with althiazide |
|
73
|
256
|
3kwaA |
Polyamines inhibit carbonic anhydrases |
|
76
|
258
|
3kokA |
Crystal structure of cobalt (ii) human carbonic anhydrase ii at ph 8.5 |
|
80
|
257
|
3kigA |
Mutant carbonic anhydrase ii in complex with an azide and an alkyne |
|
77
|
257
|
3ks3A |
High resolution structure of human carbonic anhydrase ii at 0.9 a |
|
71
|
265
|
3kldB |
Ptprg cntn4 complex |
|
73
|
258
|
3konA |
Crystal structure of cobalt (ii) human carbonic anhydrase ii at ph 11.0 |
|
72
|
256
|
3koiA |
Crystal structure of cobalt (iii) human carbonic anhydrase ii at ph 6.0 |
|
77
|
257
|
3kneA |
Carbonic anhydrase ii h64c mutant in complex with an in situ formed triazole |
|
73
|
258
|
3kkxA |
Neutron structure of human carbonic anhydrase ii |
|
71
|
263
|
3jxgA |
Ca-like domain of mouse ptprg |
|
73
|
268
|
3jxfA |
Ca-like domain of human ptprz |
|
75
|
256
|
3k2fA |
Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma |
|
70
|
263
|
3jxhC |
Ca-like domain of human ptprg |
|
79
|
258
|
3k34A |
Human carbonic anhydrase ii with a sulfonamide inhibitor |
|
76
|
257
|
3k7kA |
Crystal structure of the complex between carbonic anhydrase ii and anions |
|
73
|
258
|
3ibnA |
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic bis-sulfamate inhibitor |
|
73
|
256
|
3ieoA |
The coumarin-binding site in carbonic anhydrase: the antiepileptic lacosamide as an example |
|
73
|
257
|
3ibiA |
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic sulfamate inhibitor |
|
75
|
258
|
3ibuA |
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic sulfamate inhibitor |
|
67
|
257
|
3iaiA |
Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase ix |
|
76
|
258
|
3iblA |
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic bis-sulfamate inhibitor |
|
80
|
257
|
3hs4A |
Human carbonic anhydrase ii complexed with acetazolamide |
|
73
|
256
|
3hfpA |
Crystal structure of teh complex between ca ii and the activator mai |
|
71
|
257
|
3hktA |
Human carbonic anhydrase ii in complex with alpha-d-glucopyranosyl-(1->4)-1-thio-beta-d-glucopyranosylsulfonamide |
|
75
|
257
|
3hknA |
Human carbonic anhydrase ii in complex with (2,3,4,6-tetra-o-acetyl-beta-d-galactopyranosyl) -(1-4)-1,2,3,6-tetra-o-acetyl-1-thio-beta-d-glucopyranosylsulfonamide |
|
77
|
257
|
3hljA |
Crystal structure of human carbonic anhydrase isozyme ii with 3-methylthiobenzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamide |
|
74
|
257
|
3hkqA |
Human carbonic anhydrase ii in complex with 1-s-d-galactopyranosylsulfonamide |
|
75
|
257
|
3hkuA |
Human carbonic anhydrase ii in complex with topiramate |
|
76
|
257
|
3gz0A |
Apo-human carbonic anhydrase ii revisited: implications of the loss of a metal in protein structure, stability and solvent network |
|
66
|
262
|
3fw3A |
Crystal structure of soluble domain of ca4 in complex with dorzolamide |
|
79
|
256
|
3ffpX |
X ray structure of the complex between carbonic anhydrase ii and lc inhibitors |
|
67
|
262
|
3f7uA |
Crystal structure of soluble domain of ca4 in complex with small molecule. |
|
67
|
265
|
3f7bA |
Crystal structure of soluble domain of ca4 in complex with small molecule. |
|
74
|
256
|
3f8eA |
Coumarins are a novel class of suicide carbonic anhydrase inhibitors |
|
75
|
256
|
3f4xA |
Carbonic anhydrase inhibitors. comparison of chlorthalidone and indapamide x-ray crystal structures in adducts with isozyme ii: when three water molecules make the difference |
